The innovative process involves human cells and their interaction with naturally derived polymers that offer the extracellular matrix to regenerate the lost tissue.
StemDExo™, the first project of the start-up is using engineered exosomes derived from human osteoblasts. As the startup’s lead project, the outcome will be a personalized bone graft that utilizes engineered exosomes from the donor themselves.